{"entity":{"type":"insider","cik":"0001320267","url":"/insider/0001320267","json_url":"/insider/0001320267.json","name":"Daly David","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":25,"first":"2009-07-14","last":"2017-08-10","span_basis":"filed_date"},"name_variants":[{"name":"Daly David","source":"filing","n_filings":25,"first_seen":"2009-07-14","last_seen":"2017-08-10"}],"transactions":[{"id":4784614,"accession":"0001209191-17-048408","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-048408","line_url":"/filing/0001209191-17-048408#line-2","is_derivative":false,"issuer_cik":"0001320267","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001320267","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46872.0,"shares_display":"46,872","price_per_share":39.5,"price_display":"39.50","price_state":"stated","total_value":1851444.0,"total_display":"1,851,444.00","total_whole":"1,851,444","shares_owned_after":116261.0,"shares_owned_after_display":"116,261","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-09","filed_date":"2017-08-10","scope":"insider"},{"id":5319716,"accession":"0001209191-17-044354","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-044354","line_url":"/filing/0001209191-17-044354","is_derivative":false,"issuer_cik":"0001320267","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001320267","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6316.0,"shares_display":"6,316","price_per_share":38.84,"price_display":"38.84","price_state":"stated","total_value":245313.44,"total_display":"245,313.44","total_whole":"245,313","shares_owned_after":119748.0,"shares_owned_after_display":"119,748","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-06","filed_date":"2017-07-07","scope":"insider","n_lines":3},{"id":4358279,"accession":"0001209191-17-037656","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-037656","line_url":"/filing/0001209191-17-037656#line-1","is_derivative":false,"issuer_cik":"0001320267","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001320267","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":555.0,"shares_display":"555","price_per_share":38.3,"price_display":"38.30","price_state":"stated","total_value":21256.5,"total_display":"21,256.50","total_whole":"21,257","shares_owned_after":122577.0,"shares_owned_after_display":"122,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-01","filed_date":"2017-06-05","scope":"insider"},{"id":4444387,"accession":"0001209191-17-025569","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-025569","line_url":"/filing/0001209191-17-025569#line-1","is_derivative":false,"issuer_cik":"0001320267","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001320267","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2070.0,"shares_display":"2,070","price_per_share":31.96,"price_display":"31.96","price_state":"stated","total_value":66157.2,"total_display":"66,157.20","total_whole":"66,157","shares_owned_after":98582.0,"shares_owned_after_display":"98,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-03","filed_date":"2017-04-05","scope":"insider"},{"id":5251816,"accession":"0001209191-17-017389","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-017389","line_url":"/filing/0001209191-17-017389#line-1","is_derivative":false,"issuer_cik":"0001320267","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001320267","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":541.0,"shares_display":"541","price_per_share":25.12,"price_display":"25.12","price_state":"stated","total_value":13589.92,"total_display":"13,589.92","total_whole":"13,590","shares_owned_after":100652.0,"shares_owned_after_display":"100,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-01","filed_date":"2017-03-03","scope":"insider"},{"id":4557325,"accession":"0001209191-17-001959","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-001959","line_url":"/filing/0001209191-17-001959#line-2","is_derivative":false,"issuer_cik":"0001320267","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001320267","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2370.0,"shares_display":"2,370","price_per_share":18.49,"price_display":"18.49","price_state":"stated","total_value":43821.3,"total_display":"43,821.30","total_whole":"43,821","shares_owned_after":101193.0,"shares_owned_after_display":"101,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-04","filed_date":"2017-01-05","scope":"insider"},{"id":4557324,"accession":"0001209191-17-001959","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-001959","line_url":"/filing/0001209191-17-001959#line-1","is_derivative":false,"issuer_cik":"0001320267","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001320267","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2727.0,"shares_display":"2,727","price_per_share":17.41,"price_display":"17.41","price_state":"stated","total_value":47477.07,"total_display":"47,477.07","total_whole":"47,477","shares_owned_after":103563.0,"shares_owned_after_display":"103,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-03","filed_date":"2017-01-05","scope":"insider"},{"id":2673771,"accession":"0001209191-16-153308","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-153308","line_url":"/filing/0001209191-16-153308#line-1","is_derivative":false,"issuer_cik":"0001320267","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001320267","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":564.0,"shares_display":"564","price_per_share":19.95,"price_display":"19.95","price_state":"stated","total_value":11251.8,"total_display":"11,251.80","total_whole":"11,252","shares_owned_after":106290.0,"shares_owned_after_display":"106,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-01","filed_date":"2016-12-05","scope":"insider"},{"id":2325747,"accession":"0001209191-16-144862","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-144862","line_url":"/filing/0001209191-16-144862#line-1","is_derivative":false,"issuer_cik":"0001320267","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001320267","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2045.0,"shares_display":"2,045","price_per_share":23.65,"price_display":"23.65","price_state":"stated","total_value":48364.25,"total_display":"48,364.25","total_whole":"48,364","shares_owned_after":106854.0,"shares_owned_after_display":"106,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-04","filed_date":"2016-10-05","scope":"insider"},{"id":2180387,"accession":"0001209191-16-140050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-140050","line_url":"/filing/0001209191-16-140050#line-1","is_derivative":false,"issuer_cik":"0001320267","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001320267","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":551.0,"shares_display":"551","price_per_share":20.48,"price_display":"20.48","price_state":"stated","total_value":11284.48,"total_display":"11,284.48","total_whole":"11,284","shares_owned_after":108899.0,"shares_owned_after_display":"108,899","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-01","filed_date":"2016-09-06","scope":"insider"},{"id":2108646,"accession":"0001209191-16-131501","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-131501","line_url":"/filing/0001209191-16-131501#line-2","is_derivative":false,"issuer_cik":"0001320267","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001320267","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2130.0,"shares_display":"2,130","price_per_share":18.26,"price_display":"18.26","price_state":"stated","total_value":38893.8,"total_display":"38,893.80","total_whole":"38,894","shares_owned_after":109450.0,"shares_owned_after_display":"109,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-05","filed_date":"2016-07-06","scope":"insider"},{"id":2108644,"accession":"0001209191-16-131501","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-131501","line_url":"/filing/0001209191-16-131501#line-1","is_derivative":false,"issuer_cik":"0001320267","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001320267","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2878.0,"shares_display":"2,878","price_per_share":17.39,"price_display":"17.39","price_state":"stated","total_value":50048.42,"total_display":"50,048.42","total_whole":"50,048","shares_owned_after":111580.0,"shares_owned_after_display":"111,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-01","filed_date":"2016-07-06","scope":"insider"},{"id":2207409,"accession":"0001209191-16-126245","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-126245","line_url":"/filing/0001209191-16-126245#line-1","is_derivative":false,"issuer_cik":"0001320267","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001320267","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":472.0,"shares_display":"472","price_per_share":21.66,"price_display":"21.66","price_state":"stated","total_value":10223.52,"total_display":"10,223.52","total_whole":"10,224","shares_owned_after":114458.0,"shares_owned_after_display":"114,458","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-03","filed_date":"2016-06-07","scope":"insider"},{"id":2368183,"accession":"0001209191-16-105257","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-105257","line_url":"/filing/0001209191-16-105257#line-1","is_derivative":false,"issuer_cik":"0001320267","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001320267","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":701.0,"shares_display":"701","price_per_share":15.14,"price_display":"15.14","price_state":"stated","total_value":10613.14,"total_display":"10,613.14","total_whole":"10,613","shares_owned_after":44930.0,"shares_owned_after_display":"44,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-01","filed_date":"2016-03-03","scope":"insider"},{"id":8803818,"accession":"0001209191-15-083188","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-083188","line_url":"/filing/0001209191-15-083188#line-1","is_derivative":false,"issuer_cik":"0001320267","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001320267","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2559.0,"shares_display":"2,559","price_per_share":16.7825,"price_display":"16.78","price_state":"stated","total_value":42946.4175,"total_display":"42,946.42","total_whole":"42,946","shares_owned_after":45631.0,"shares_owned_after_display":"45,631","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-01","filed_date":"2015-12-03","scope":"insider"},{"id":7721837,"accession":"0001179110-10-009758","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-10-009758","line_url":"/filing/0001179110-10-009758#line-1","is_derivative":false,"issuer_cik":"0001038223","issuer_name":"CLARIENT, INC","issuer_ticker":"CLRT","issuer_name_source":null,"issuer_url":"/issuer/0001038223","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Sr. VP of Commercial Ops)","role_mark":"O","role_mark_label":"Officer (Sr. VP of Commercial Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP of Commercial Ops","security_title":"Clarient common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":2.96,"price_display":"2.96","price_state":"stated","total_value":4736.0,"total_display":"4,736.00","total_whole":"4,736","shares_owned_after":154309.0,"shares_owned_after_display":"154,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-01","filed_date":"2010-06-02","scope":"insider"},{"id":7584714,"accession":"0001179110-10-007719","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-10-007719","line_url":"/filing/0001179110-10-007719#line-1","is_derivative":false,"issuer_cik":"0001038223","issuer_name":"CLARIENT, INC","issuer_ticker":"CLRT","issuer_name_source":null,"issuer_url":"/issuer/0001038223","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Sr. VP of Commercial Ops)","role_mark":"O","role_mark_label":"Officer (Sr. VP of Commercial Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP of Commercial Ops","security_title":"Clarient common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1810.0,"shares_display":"1,810","price_per_share":3.17,"price_display":"3.17","price_state":"stated","total_value":5737.7,"total_display":"5,737.70","total_whole":"5,738","shares_owned_after":155909.0,"shares_owned_after_display":"155,909","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-03","filed_date":"2010-05-03","scope":"insider"},{"id":7622798,"accession":"0001179110-10-006500","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-10-006500","line_url":"/filing/0001179110-10-006500#line-1","is_derivative":false,"issuer_cik":"0001038223","issuer_name":"CLARIENT, INC","issuer_ticker":"CLRT","issuer_name_source":null,"issuer_url":"/issuer/0001038223","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Sr. VP of Commercial Ops)","role_mark":"O","role_mark_label":"Officer (Sr. VP of Commercial Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP of Commercial Ops","security_title":"Clarient common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1575.0,"shares_display":"1,575","price_per_share":2.66,"price_display":"2.66","price_state":"stated","total_value":4189.5,"total_display":"4,189.50","total_whole":"4,190","shares_owned_after":157719.0,"shares_owned_after_display":"157,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-05","filed_date":"2010-04-05","scope":"insider"},{"id":7584460,"accession":"0001179110-10-004113","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-10-004113","line_url":"/filing/0001179110-10-004113#line-1","is_derivative":false,"issuer_cik":"0001038223","issuer_name":"CLARIENT, INC","issuer_ticker":"CLRT","issuer_name_source":null,"issuer_url":"/issuer/0001038223","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Sr. VP of Commercial Ops)","role_mark":"O","role_mark_label":"Officer (Sr. VP of Commercial Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP of Commercial Ops","security_title":"Clarient common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":1.96,"price_display":"1.96","price_state":"stated","total_value":4116.0,"total_display":"4,116.00","total_whole":"4,116","shares_owned_after":159294.0,"shares_owned_after_display":"159,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-01","filed_date":"2010-03-02","scope":"insider"},{"id":7664644,"accession":"0001179110-10-002066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-10-002066","line_url":"/filing/0001179110-10-002066#line-1","is_derivative":false,"issuer_cik":"0001038223","issuer_name":"CLARIENT, INC","issuer_ticker":"CLRT","issuer_name_source":null,"issuer_url":"/issuer/0001038223","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Sr. VP of Commercial Ops)","role_mark":"O","role_mark_label":"Officer (Sr. VP of Commercial Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP of Commercial Ops","security_title":"Clarient common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1950.0,"shares_display":"1,950","price_per_share":2.21,"price_display":"2.21","price_state":"stated","total_value":4309.5,"total_display":"4,309.50","total_whole":"4,310","shares_owned_after":161394.0,"shares_owned_after_display":"161,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-04","filed_date":"2010-02-04","scope":"insider"},{"id":7420772,"accession":"0001179110-10-000255","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-10-000255","line_url":"/filing/0001179110-10-000255#line-1","is_derivative":false,"issuer_cik":"0001038223","issuer_name":"CLARIENT, INC","issuer_ticker":"CLRT","issuer_name_source":null,"issuer_url":"/issuer/0001038223","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Sr. VP of Commercial Ops)","role_mark":"O","role_mark_label":"Officer (Sr. VP of Commercial Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP of Commercial Ops","security_title":"Clarient common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1850.0,"shares_display":"1,850","price_per_share":2.72,"price_display":"2.72","price_state":"stated","total_value":5032.0,"total_display":"5,032.00","total_whole":"5,032","shares_owned_after":163344.0,"shares_owned_after_display":"163,344","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-05","filed_date":"2010-01-05","scope":"insider"},{"id":5611986,"accession":"0001179110-09-016207","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-09-016207","line_url":"/filing/0001179110-09-016207#line-1","is_derivative":false,"issuer_cik":"0001038223","issuer_name":"CLARIENT, INC","issuer_ticker":"CLRT","issuer_name_source":null,"issuer_url":"/issuer/0001038223","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Sr. VP of Commercial Ops)","role_mark":"O","role_mark_label":"Officer (Sr. VP of Commercial Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP of Commercial Ops","security_title":"Clarient common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":2.43,"price_display":"2.43","price_state":"stated","total_value":4252.5,"total_display":"4,252.50","total_whole":"4,253","shares_owned_after":165194.0,"shares_owned_after_display":"165,194","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-02","filed_date":"2009-12-03","scope":"insider"},{"id":5602538,"accession":"0001179110-09-015029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-09-015029","line_url":"/filing/0001179110-09-015029#line-1","is_derivative":false,"issuer_cik":"0001038223","issuer_name":"CLARIENT, INC","issuer_ticker":"CLRT","issuer_name_source":null,"issuer_url":"/issuer/0001038223","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Sr. VP of Commercial Ops)","role_mark":"O","role_mark_label":"Officer (Sr. VP of Commercial Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP of Commercial Ops","security_title":"Clarient common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1675.0,"shares_display":"1,675","price_per_share":3.09,"price_display":"3.09","price_state":"stated","total_value":5175.75,"total_display":"5,175.75","total_whole":"5,176","shares_owned_after":166944.0,"shares_owned_after_display":"166,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-03","filed_date":"2009-11-04","scope":"insider"},{"id":5973977,"accession":"0001179110-09-014211","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-09-014211","line_url":"/filing/0001179110-09-014211#line-1","is_derivative":false,"issuer_cik":"0001038223","issuer_name":"CLARIENT, INC","issuer_ticker":"CLRT","issuer_name_source":null,"issuer_url":"/issuer/0001038223","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Sr. VP of Commercial Ops)","role_mark":"O","role_mark_label":"Officer (Sr. VP of Commercial Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP of Commercial Ops","security_title":"Clarient common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1540.0,"shares_display":"1,540","price_per_share":4.15,"price_display":"4.15","price_state":"stated","total_value":6391.0,"total_display":"6,391.00","total_whole":"6,391","shares_owned_after":168619.0,"shares_owned_after_display":"168,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-05","filed_date":"2009-10-05","scope":"insider"},{"id":5641762,"accession":"0001179110-09-012927","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-09-012927","line_url":"/filing/0001179110-09-012927#line-1","is_derivative":false,"issuer_cik":"0001038223","issuer_name":"CLARIENT, INC","issuer_ticker":"CLRT","issuer_name_source":null,"issuer_url":"/issuer/0001038223","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Sr. VP of Commercial Ops)","role_mark":"O","role_mark_label":"Officer (Sr. VP of Commercial Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP of Commercial Ops","security_title":"Clarient common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1525.0,"shares_display":"1,525","price_per_share":4.05,"price_display":"4.05","price_state":"stated","total_value":6176.25,"total_display":"6,176.25","total_whole":"6,176","shares_owned_after":170159.0,"shares_owned_after_display":"170,159","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-03","filed_date":"2009-09-04","scope":"insider"},{"id":5857145,"accession":"0001179110-09-011671","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-09-011671","line_url":"/filing/0001179110-09-011671","is_derivative":false,"issuer_cik":"0001038223","issuer_name":"CLARIENT, INC","issuer_ticker":"CLRT","issuer_name_source":null,"issuer_url":"/issuer/0001038223","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Sr. VP of Commercial Ops)","role_mark":"O","role_mark_label":"Officer (Sr. VP of Commercial Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP of Commercial Ops","security_title":"Clarient common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1616.0,"shares_display":"1,616","price_per_share":3.740315594059406,"price_display":"3.74","price_state":"stated","total_value":6044.35,"total_display":"6,044.35","total_whole":"6,044","shares_owned_after":171735.0,"shares_owned_after_display":"171,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-06","filed_date":"2009-08-06","scope":"insider","n_lines":2},{"id":5705292,"accession":"0001179110-09-010855","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-09-010855","line_url":"/filing/0001179110-09-010855","is_derivative":false,"issuer_cik":"0001038223","issuer_name":"CLARIENT, INC","issuer_ticker":"CLRT","issuer_name_source":null,"issuer_url":"/issuer/0001038223","owner_cik":"0001320267","owner_name":"Daly David","owner_display_name":"Daly David","owner_url":"/insider/0001320267","role":"Officer (Sr. VP of Commercial Ops)","role_mark":"O","role_mark_label":"Officer (Sr. VP of Commercial Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP of Commercial Ops","security_title":"Clarient common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26700.0,"shares_display":"26,700","price_per_share":3.282546816479401,"price_display":"3.28","price_state":"stated","total_value":87644.0,"total_display":"87,644.00","total_whole":"87,644","shares_owned_after":173300.0,"shares_owned_after_display":"173,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-13","filed_date":"2009-07-14","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":31,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":31,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":31},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001488613","name":"Foundation Medicine, Inc.","url":"/issuer/0001488613","role":"Officer (Chief Commercial Officer)","n_filings":13,"first_seen":"2015-12-03","last_seen":"2017-08-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001038223","name":"CLARIENT, INC","url":"/issuer/0001038223","role":"Officer (Sr. VP of Commercial Ops)","n_filings":12,"first_seen":"2009-07-14","last_seen":"2010-06-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001320267","retrieved_at":"2026-08-25T16:37:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}